- Home
- PDI vs LNTH Comparison
PDI vs LNTH Comparison
Compare PDI & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDI
- LNTH
- Stock Information
- Founded
- PDI 2012
- LNTH 1956
- Country
- PDI United States
- LNTH United States
- Employees
- PDI N/A
- LNTH N/A
- Industry
- PDI Trusts Except Educational Religious and Charitable
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- PDI Finance
- LNTH Health Care
- Exchange
- PDI Nasdaq
- LNTH Nasdaq
- Market Cap
- PDI 7.1B
- LNTH 7.5B
- IPO Year
- PDI N/A
- LNTH 2015
- Fundamental
- Price
- PDI $18.97
- LNTH $82.13
- Analyst Decision
- PDI
- LNTH Strong Buy
- Analyst Count
- PDI 0
- LNTH 5
- Target Price
- PDI N/A
- LNTH $131.20
- AVG Volume (30 Days)
- PDI 1.5M
- LNTH 1.0M
- Earning Date
- PDI 01-01-0001
- LNTH 07-30-2025
- Dividend Yield
- PDI 13.81%
- LNTH N/A
- EPS Growth
- PDI N/A
- LNTH N/A
- EPS
- PDI N/A
- LNTH 3.53
- Revenue
- PDI N/A
- LNTH $1,536,699,000.00
- Revenue This Year
- PDI N/A
- LNTH $4.63
- Revenue Next Year
- PDI N/A
- LNTH $9.35
- P/E Ratio
- PDI N/A
- LNTH $23.14
- Revenue Growth
- PDI N/A
- LNTH 12.53
- 52 Week Low
- PDI $15.45
- LNTH $73.11
- 52 Week High
- PDI $19.60
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- PDI 57.00
- LNTH 51.77
- Support Level
- PDI $18.80
- LNTH $78.61
- Resistance Level
- PDI $18.77
- LNTH $81.72
- Average True Range (ATR)
- PDI 0.07
- LNTH 2.49
- MACD
- PDI 0.01
- LNTH 0.75
- Stochastic Oscillator
- PDI 64.15
- LNTH 64.21
About PDI PIMCO Dynamic Income Fund
PIMCO Dynamic Income Fund is a United States-based closed-end management investment company. The fund's investment objective is to seek current income. Its secondary objective is to seek capital appreciation. The fund invests world-wide in a portfolio of debt obligations and other income-producing securities with varying maturities and related derivative instruments. Its investments include mortgage-backed securities, investment grade, and high-yield corporates, corporate and sovereign bonds, other income-producing securities, and related derivative instruments.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.